In a Thursday interview with CNBC’s Jim Cramer, GE Healthcare CEO Peter Arduini said a lot of his company’s research and development efforts are focused on artificial intelligence.
Arduini went through several ways AI can enhance health-care workers’ productivity, including technology that makes patient data more cohesive.
“The last piece, which we’re assembling now and will evolve in the next few years, is what’s called multimodal data integration — your genomics information, your pathology information, your image data,” he said. “All together on one pane of glass, and a given algorithm, or foundational model, that can help decipher through that data and help your clinician move you in the right direction.”
Arduini also described how AI can be used in MRIs, CTs and ultrasounds to heighten imaging, claiming that customers are willing to pay more for these advanced products. He added that GE Healthcare’s R&D investments over the past year created a pipeline of 40 new products that will have a “flywheel effect” on the business.
Arduini also reflected on GE Healthcare’s first year as an independent company from GE, saying that independence enabled progress.
“Focus is a lot. We have a very focused board, we have people coming to us that really are dedicated to health care,” he said. “We’ve been able to free up our own balance sheet to invest across the company.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Disclaimer The CNBC Investing Club Charitable Trust holds shares of GE Healthcare.
Eugen Boglaru is an AI aficionado covering the fascinating and rapidly advancing field of Artificial Intelligence. From machine learning breakthroughs to ethical considerations, Eugen provides readers with a deep dive into the world of AI, demystifying complex concepts and exploring the transformative impact of intelligent technologies.